ChromaDex (CDXC) Reports In-Line Q4 EPS, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. CVS
9. SPY
10. XYZ

Go back to ChromaDex (CDXC) Reports In-Line Q4 EPS, Revenues Beat

CHROMADEX CORPORATION REPORTS 2019 FINANCIAL RESULTS

March 10, 2020 4:01 PM EDT

Fourth Quarter 2019 Highlights vs. Fourth Quarter 2018

Strong growth in net sales to $13.1 million, higher gross margins, and significantly improved marketing efficiency year-over-year.Tru Niagen® net sales of $10.2 million, a 57% increase year-over-year.Net loss per share of ($0.15) as reported, or non-GAAP net loss per share of ($0.11) excluding a $0.04 per share charge related to the non-cash write-off of Elysium receivable as bad debt expense.Expanded distribution rights with Matakana in Australia and secured partnership with a leading health and beauty retailer to launch in over 200 U.K. stores in... More